Filing Details
- Accession Number:
- 0001209191-17-051112
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-09-01 21:33:44
- Reporting Period:
- 2017-09-01
- Accepted Time:
- 2017-09-01 20:33:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1533040 | Rxi Pharmaceuticals Corp | RXII | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1694380 | Alexey Eliseev | C/O 257 Simarano Drive, Suite 101 Marlborough MA 01752 | Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 Par Value | Disposition | 2017-09-01 | 23,200 | $0.57 | 1,127,112 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- Represents the weighted average sale price. The highest price at which shares were sold was $0.58 and the lowest price at which shares were sold was $0.56.The reporting person hereby undertakes to provide upon request to the SEC staff or other appropriate persons full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
